Court revives doctors' lawsuit saying FDA overstepped its authority with anti-ivermectin campaign
The IndependentThe latest headlines from our reporters across the US sent straight to your inbox each weekday Your briefing on the latest headlines from across the US Your briefing on the latest headlines from across the US SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy A federal appeals court Friday revived a lawsuit by three doctors who say the Food and Drug Administration overstepped its authority in a campaign against treating COVID-19 with the anti-parasite drug ivermectin. Circuit Court of Appeal in New Orleans focused on various aspects of an FDA campaign against ivermectin as a COVID-19 treatment. The doctors can proceed with their lawsuit contending that the FDA's campaign exceeded the agency's authority under federal law, the ruling said. The lawsuit was dismissed in December by U.S. District Judge Jeffrey Vincent Brown, who ruled that the complaints didn't overcome the FDA's “sovereign immunity,” a concept that protects government entities from many civil lawsuits regarding their responsibilities.